News & Analysis as of

Partnerships Acquisitions Private Equity

Levenfeld Pearlstein, LLC

Independent Sponsor Series: A Conversation with Ryan Sullivan on North Park Group’s Unique Background and Long-Term Strategy (Part...

To help businesses, investors, and deal professionals better understand the evolving independent sponsor landscape, Robert Connolly – a partner in LP’s Corporate Practice Group and leader of LP’s Independent Sponsor team –...more

Benesch

Dental/DSO Intelligence Monthly Report: April 2025

Benesch on

DSOs have experienced several challenges amid the slowing private equity space in the years since the COVID-19 pandemic and the tightening of the private equity space, however, there are signs of a shift, with a number of...more

Goodwin

Five Trends Reshaping Pharmaceutical Manufacturing Partnerships

Goodwin on

How CDMOs are reshaping pharmaceutical partnerships through friendshoring, risk-sharing economics, and specialized development capabilities. The pharmaceutical manufacturing landscape is undergoing a profound shift, with...more

Benesch

Dental/DSO Intelligence Monthly Report: September/October 2024

Benesch on

Dentologie shares thoughts on growth by building on its unique brand identity - While other DSOs have focused on growth through acquisitions, Dentologie instead builds on its unique culture, modern aesthetic, and consumer...more

Davis Wright Tremaine LLP

Food Venture Financing News - Weekly Issue No. 212

Keurig Dr Pepper announced that it plans to acquire GHOST, an energy drink brand, for $1 billion. J.M. Smucker will plan to sell its Voortman cookie business to Second Nature Brands for $305 million....more

Benesch

Dental/DSO Intelligence Monthly Report: July/August 2024

Benesch on

Background on Indiana’s “Baby HSR” Law - Indiana passed Senate Bill 9 in March 2024, which requires an Indiana healthcare entity involved in a merger or acquisition with another healthcare entity with a value of at least...more

Skadden, Arps, Slate, Meagher & Flom LLP

Real World Examples Where Conflicts Tainted a Deal Process, and Other Deals That Were Insulated From Conflicts

Sometimes when a board is considering a strategic transaction, it may find that a key figure who can influence the deal process — for example, a founder, controller or CEO-negotiator — has a potential conflict of interest....more

White & Case LLP

Sector trends - September 2023: Stock Exchanges/Clearing Houses/Trading Venues

White & Case LLP on

Decisive inorganic growth decisions by London Stock Exchange, Deutsche Börse, Nasdaq and Euronext set a furious pace for European trading venue M&A activity....more

White & Case LLP

Sector trends - September 2023: Brokers/Corporate Finance

White & Case LLP on

Pan-European banks, including Mediobanca and Deutsche Bank, seek senior dealmaker bench strength through high profile acquisitions....more

Benesch

Benesch DSO Intelligence Quarterly Report: Q2 2023

Benesch on

Younger Dentists are Affiliating with DSOs at Higher Rates in the U.S. Financial constraints, stronger need for work/life balance is driving this trend - The ADA Health Policy Institute (HPI) released data in May that...more

McDermott Will & Emery

[Event] 2022 Hospitals & Health Systems Innovation Summit - October 20th, New York, NY

McDermott Will & Emery on

Join us for our third annual Hospitals & Health Systems Innovation Summit and connect with C-suite executives, in-house counsel and other industry leaders as they share insights on how to innovate, collaborate and grow in a...more

Rivkin Radler LLP

The Tax-Deferred Rollover – Some Considerations

Rivkin Radler LLP on

“I have wondered at times what the Ten Commandments would have looked like if Moses had run them through the U.S. Congress.” – Pres. Ronald Regan- That line probably describes the exasperation with which many Americans...more

Rivkin Radler LLP

Selling to Private Equity? Maybe You Should “F Reorg” First

Rivkin Radler LLP on

Having Fun? Hope you had a decent weekend. Perhaps you did something interesting, maybe even fun, like some end-of-season apple picking? Or maybe you had a cider donut with some hot coffee at a farm stand you stumbled upon...more

Herbert Smith Freehills Kramer

Proposed Tax Law Amendments and Tax Increases May Impact Private Equity and M&A Deals

The House Ways and Means Committee recently released legislative proposals as part of the “Build Back Better” reconciliation legislation that the committee is currently developing (the Proposed Legislation). The Proposed...more

McDermott Will & Emery

[Virtual Event] 2021 J.P. Morgan Healthcare Conference - Life Sciences Investment Forum - January 11th, 10:00 am - 1:00 pm EST

You won’t want to miss four days of exclusive, virtual events that bring together industry leaders, emerging standouts, innovators and investors from across the industry landscape at the largest healthcare investment...more

McDermott Will & Emery

Proposed HSR Rule Changes Likely to Increase Filings and Information Requirements for Private Equity Firms

McDermott Will & Emery on

What Happened: - The FTC and DOJ proposed new Hart–Scott–Rodino (HSR) rules that, if issued in final form, will significantly change HSR practice for Private Equity (PE) companies. - The Proposed Rules are subject to...more

Bass, Berry & Sims PLC

10 Trends in Physician Practice Transactions to Track in 2020

Bass, Berry & Sims PLC on

By all accounts, 2019 proved to be another year of significant investment by private equity firms in the physician practice space. Below we discuss 10 trends we observed as counsel on a number of these transactions during...more

Foley & Lardner LLP

A Round Up of Key Trends in Health Care Private Equity Investments

Foley & Lardner LLP on

This conference season, private equity (PE) investors and provider compared notes on the current state of the markets, trends, opportunities and challenges...more

McDermott Will & Emery

Strategies for Maximizing Physician Practice Management Investments

Private equity continues to fuel robust activity in the physician practice management (PPM) sector. Within the last five to seven years, not only have PPMs within traditional areas of medicine proliferated, but new...more

McDermott Will & Emery

Dealmaking in Life Sciences – Valuations and Partnerships that Work

McDermott Will & Emery on

Technology companies are pouring unprecedented capital, time and energy into the health care and life sciences industry, and are reshaping the deal landscape in the process. The top 10 US tech companies have made $4.7 billion...more

20 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide